Resultados de la búsqueda 371-380 of 2125 for chemical peels

  1. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric ...

  2. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to develop a pan-gynecologic cancer detection test using gynecologic (unique endometrial, cervical, and ovarian cancer) ...

  3. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the integration of cancer pan-genetic testing into a cancer clinical practice and understand both its use and effect in ...

  4. Oncología (médica) - Ensayos clínicos

    This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

  5. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  6. Oncología (médica) - Ensayos clínicos

    Patients with recurrent, platinum-sensitive high-grade serous ovarian cancer (HGSOC) including fallopian tube and primary peritoneal cancer expressing high ...

  7. Cuerpo extraño en la piel: primeros auxilios - Mayo Clinic

    Litin SC, et al., eds. First aid and emergency care. In: Mayo Clinic Family Health Book. 5th ed. · Thompson DA. Skin, foreign body. In: Adult Telephone Protocols ...

  8. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  9. Cirugía estética de cejas - Médicos y departamentos - Mayo Clinic

    Surgery of the Skin. https://www.clinicalkey.com. Accessed Aug. 14, 2018. National Blood Clot Alliance. Blood clot info: Risks, symptoms, and prevention ...

  10. Oncología (médica) - Ensayos clínicos

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...